PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 9, 2008 Subscribe to this News Feed    
 

Founding Medical Directors Appointed

LifeGuard Health announces the appointment of the founding medical directors for Omega Eye Health, a subsidiary of LifeGuard Health. Dr. Frank A. Bucci, Jr. and Dr. Thomas P. Kislan, are the initial members of Omega Eye Health's Medical Advisory Panel.

Plymouth Meeting, PA (Bluehost/PRWEB ) October 9, 2008 -- Dr. Michael B. Gross, MD, FACOG, VP and Chief Medical Officer of LifeGuard Health announces the appointment of the founding medical directors for Omega Eye Health, a subsidiary of LifeGuard Health. Dr. Frank A. Bucci, Jr. and Dr. Thomas P. Kislan, are the initial members of Omega Eye Health's Medical Advisory Panel. The Medical Advisory Panel will be comprised of nationally prominent ophthalmologists and optometrists.

Dr. Frank A. Bucci, Jr., M.D is the founder and Medical Director of Bucci Laser Vision Institute and Ambulatory Surgery Center in Wilkes-Barre, PA. He is a fellowship-trained corneal, refractive and cataract specialist who completed a prestigious Lindstrom fellowship.

In 2007, Dr. Bucci received the "Achievement Award" from the American Academy of Ophthalmology for his outstanding contributions in the field of ophthalmology. Dr. Bucci has also just completed an Eye Institute and Surgery Center in Lima, Peru, designed specifically for performing cataract and other ophthalmic surgeries for the poor in this country. He was recently voted by his peers as one of the top 50 ophthalmologists in the United States as published in Cataract and Refractive Surgery Today (2007).

Dr. Thomas P. Kislan, O.D. is the founder and Medical Director of Stroudsburg Eye Specialists, Hazleton Eye Specialists and Dry Eye Clinic of Northeastern Pennsylvania. These practices are large multi-disciplinary eye care facilities which provide medical eye care for the treatment and management of ocular diseases including; cataracts, glaucoma, dry eye disease, diabetic retinopathy and macular degeneration.

Dr. Kislan is a prominent lecturer and speaks nationally on Dry Eye Disease, Glaucoma, Ophthalmic use of Omega-3 Fatty Acids and the management of Refractive Surgery. Dr. Kislan participates in clinical research which has been published in many peer-reviewed journals.

Omega Eye Health will distinguish itself by offering its specially formulated omega-3 nutritional eye care products exclusively to ophthalmologists and optometrists. As stated by Mr. Robert D. Bauer, President of Omega Eye Health, "Omega Eye Health is honored to have Drs. Bucci and Kislan as our initial medical advisory panel members. By establishing these two doctors as strategic resources, we will be optimally equipped to formulate and provide the best omega-3 evidence based nutriceuticals in the eye health arena."


For additional information, contact Robert Bauer or visit www.omegaeyehealth.com.
Robert D. Bauer
President
Omega Eye Health and
LifeGuard Health, LLC
610-862-0182
www.lifeguardforlife.com

###

See the original story at: http://bluehost.prweb.com/releases/2008/10/prweb1438694.htm

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1DcmFzLVBpZ2ctUHJvZi1IYWxmLVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Web Master
Omega Eye Health, LLC
610-862-0182
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move